Project Engage: Oral PrEP Acceptability
Conditions:   Acceptability of Health Care;   Adherence, Medication Interventions:   Drug: emtricitabine/tenofovir alafenamide;   Drug: Emtricitabine / Tenofovir Disoproxil Oral Tablet Sponsors:   Eastern Virginia Medical School;   CONRAD;   FHI 360;   United States Agency for International Development (USAID);   Gilead Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials